Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul 28;10(8):1302.
doi: 10.3390/children10081302.

Treatment of High-Risk Neuroblastoma

Julie Krystal  1 , Jennifer H Foster  2
Affiliations
Review

Treatment of High-Risk Neuroblastoma

Julie Krystal et al. Children (Basel). .

Abstract

High-risk neuroblastoma is a highly aggressive solid tumor that most commonly presents in early childhood. Advances in treatment through decades of clinical trials and research have led to improved outcomes. This review provides an overview of the current state of treatment for high-risk neuroblastoma.

Keywords: neuroblastoma; pediatric oncology; solid tumor.

PubMed Disclaimer

Conflict of interest statement

Foster has participated in Advisory Boards for Y-mAbs Therapeutics Inc.

Figures

Figure 1
Figure 1
Treatment of high-risk neuroblastoma.
See this image and copyright information in PMC

References

    1. Park J.R., Hogarty M.D., Bagatell R. Chapter 23: Neuroblastoma. In: Blaney S.M., Adamson P.C., Helman L.J., editors. Pizzo and Poplack’s Principles and Practice of Pediatric Oncology. 8th ed. Williams and Wilkins; Philadelphia, PA, USA: 2021.
    1. DuBois S.G., Macy M.E., Henderson T.O. High-Risk and Relapsed Neuroblastoma: Toward More Cures and Better Outcomes. Am. Soc. Clin. Oncol. Educ. Book. 2022;42:768–780. doi: 10.1200/EDBK_349783. - DOI - PubMed
    1. Cohn S.L., Pearson A.D., London W.B., Monclair T., Ambros P.F., Brodeur G.M., Faldum A., Hero B., Iehara T., Machin D., et al. The International Neuroblastoma Risk Group (INRG) classification system: An INRG Task Force report. J. Clin. Oncol. 2009;27:289–297. doi: 10.1200/JCO.2008.16.6785. - DOI - PMC - PubMed
    1. Monclair T., Brodeur G.M., Ambros P.F., Brisse H.J., Cecchetto G., Holmes K., Kaneko M., London W.B., Matthay K.K., Nuchtern J.G., et al. The International Neuroblastoma Risk Group (INRG) staging system: An INRG Task Force report. J. Clin. Oncol. 2009;27:298–303. doi: 10.1200/JCO.2008.16.6876. - DOI - PMC - PubMed
    1. Irwin M.S., Naranjo A., Zhang F.F., Cohn S.L., London W.B., Gastier-Foster J.M., Ramirez N.C., Pfau R., Reshmi S., Wagner E., et al. Revised Neuroblastoma Risk Classification System: A Report from the Children’s Oncology Group. J. Clin. Oncol. 2021;39:3229–3241. doi: 10.1200/JCO.21.00278. - DOI - PMC - PubMed

LinkOut - more resources